Piper Jaffray Cuts Price Target on Endologix (ELGX) to $20 Following 2Q15

Go back to Piper Jaffray Cuts Price Target on Endologix (ELGX) to $20 Following 2Q15

JPMorgan Upgrades Endologix (ELGX) to Overweight

August 6, 2015 6:46 AM EDT

JPMorgan upgraded Endologix (NASDAQ: ELGX) from Neutral to Overweight with a price target of $17.00.

For an analyst ratings summary and ratings history on Endologix click here. For more ratings news on Endologix click here.

Shares of Endologix closed at $12.05 yesterday.

... More

Canaccord Genuity Downgrades Endologix (ELGX) to Hold

August 4, 2015 7:03 AM EDT

Canaccord Genuity downgraded Endologix (NASDAQ: ELGX) from Buy to Hold with a price target of $14.00 (from $18.50).

For an analyst ratings summary and ratings history on Endologix click here. For more ratings news on Endologix click here.

Shares of Endologix closed at $14.06 yesterday.

... More

Endologix (ELGX) Misses Q2 EPS by 5c

August 3, 2015 4:08 PM EDT

Endologix (NASDAQ: ELGX) reported Q2 EPS of ($0.18), $0.05 worse than the analyst estimate of ($0.13). Revenue for the quarter came in at $39.5 million versus the consensus estimate of $39.35 million.

For earnings history and earnings-related data on Endologix (ELGX) click here.

... More

Trading Radar for 7/31: Loews (L), Clorox (CLX), Tenet Healthcare (THC), Broadsoft (BSFT) Report

July 31, 2015 3:34 PM EDT

The Trading Radar highlights key earnings and economic announcements for the next trading session:

Before Markets Open:
Economics:
8:30am EDT

Personal Income - Street sees 0.3%Personal Spending - Street sees 0.2%PCE Prices: Core - Street sees 0.2%

Earnings:

ArcBest (Nasdaq: ARCB) - consensus EPS $0.76
Array Biopharma (Nasdaq: ARRY) - consensus loss $0.16
Boardwalk Pipeline Partners (NYSE: BWP) - no Street consensus
Broadsoft (Nasdaq:... More